⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7088874 | 0.96 | — | — | |
| SCHEMBL4416860 | 0.87 | — | — | |
| Diaminooctane SCHEMBL8650707 | 0.82 | DNM1 (1.00) | — | |
| SCHEMBL595181 | 0.82 | CA12 (0.33) | — | |
| SCHEMBL592679 | 0.82 | — | — | |
| SCHEMBL25262966 | 0.82 | DNM1 (1.00) | — | |
| SCHEMBL22684932 | 0.82 | DNM1 (1.00) | — | |
| SCHEMBL22283336 | 0.82 | DNM1 (1.00) | — | |
| SCHEMBL22684930 | 0.82 | DNM1 (1.00) | — | |
| SCHEMBL11366940 | 0.82 | DNM1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111378161-A | Energy absorption method and application thereof | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| EP-1830832-A1 | ZINC-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA | Genzyme Corporation (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006072054-A1 | ZINC-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA | GENZYME CORPORATION (US) | 2006-07-06 | — | — | WO | disclosed |